Healthcare Resource Utilization and Projected Long-Term Cost Savings Following Clobazam Initiation in Patients With Lennox-Gastaut Syndrome

被引：0
|
作者：
Stern, John M. [1 ]
Ogbonnaya, Augustina [2 ]
Lokhandwala, Tasneem [2 ]
Landsman-Blumberg, Pamela [2 ]
Duhig, Amy [2 ]
Hantrakul, Aroonrut J. [3 ]
Kymes, Steven [3 ]
Francois, Clement [3 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Xcenda LLC, Palm Harbor, FL USA
[3] Lundbeck LLC, Deerfield, IL USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.104
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Healthcare Resource Utilization Among Patients With Lennox-Gastaut Syndrome Treated With Clobazam
    Pina-Garza, J. Eric
    Montouris, Georgia D.
    Vekeman, Francis
    Cheng, Wendy Y.
    Tuttle, Edward
    Shen, Yuanyuan
    Duh, Mei Sheng
    Isojarvi, Jouko
    Kymes, Steven
    Saurer, Timothy B.
    NEUROLOGY, 2017, 88
  • [2] Clobazam In Patients with Lennox-Gastaut Syndrome
    Yang, Lily P. H.
    Scott, Lesley J.
    CNS DRUGS, 2012, 26 (11) : 983 - 991
  • [3] Healthcare Resource Utilization Among Commercially Insured Clobazam-Treated Patients with Lennox-Gastaut Syndrome
    Francois, Clement
    Stern, John
    Ogbonnaya, Augustina
    Lokhandwala, Tasneem
    Landsman-Blumberg, Pamela
    Duhig, Amy
    Shen, Vivienne
    NEUROLOGY, 2016, 86
  • [4] Changes in Healthcare Resource Utilization Among Medicaid Patients with Lennox-Gastaut Syndrome Initiating Clobazam Treatment
    Stern, John
    Francois, Clement
    Ogbonnaya, Augustina
    Lokhandwala, Tasneem
    Landsman-Blumberg, Pamela
    Duhig, Amy
    Shen, Vivienne
    NEUROLOGY, 2016, 86
  • [5] Healthcare Resource Utilization Among Commercially Insured Clobazam-Treated Patients with Lennox-Gastaut Syndrome
    Francois, Clement
    Stern, John
    Ogbonnaya, Augustina
    Lokhandwala, Tasneem
    Landsman-Blumberg, Pamela
    Duhig, Amy
    Shen, Vivienne
    NEUROLOGY, 2016, 86
  • [6] DOES THE COMMERCIAL AVAILABILITY OF CLOBAZAM AFFECT HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH LENNOX-GASTAUT SYNDROME?
    Francois, C.
    Stem, J. M.
    Ogbonnaya, A.
    Lokhandwala, T.
    Duhig, A.
    Shen, V
    Tan, R.
    Kymes, S.
    VALUE IN HEALTH, 2017, 20 (05) : A191 - A191
  • [7] Clobazam for patients with Lennox-Gastaut syndrome and epilepsy
    Seif-Eddeine, Hussam
    Ng, Yu-Tze
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 385 - 393
  • [8] HEALTHCARE COSTS AMONG PATIENTS WITH LENNOX-GASTAUT SYNDROME TREATED WITH CLOBAZAM
    Pina-Garza, J. E.
    Montouris, C. D.
    Vekeman, F.
    Cheng, W. Y.
    Tuttle, E.
    Shen, Y.
    Duh, M. S.
    Chatamra, K.
    Kymes, S. M.
    VALUE IN HEALTH, 2017, 20 (05) : A191 - A191
  • [9] LONG-TERM PROGNOSIS OF LENNOX-GASTAUT SYNDROME
    FURUNE, S
    WATANABE, K
    NEGORO, T
    MIYAZAKI, S
    TAKEUCHI, T
    MATSUMOTO, A
    KUMAGAI, T
    NOMURA, K
    YAMAMOTO, N
    TAKAHASHI, I
    MAEHARA, M
    JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1987, 41 (03): : 444 - 445
  • [10] LONG-TERM PROGNOSIS OF THE LENNOX-GASTAUT SYNDROME
    OHTSUKA, Y
    AMANO, R
    MIZUKAWA, M
    OHTAHARA, S
    JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1990, 44 (02): : 257 - 264
12345